Ipratropium Bromide

Drug Class: Respiratory Drugs
Dosage Form: Inhaler
Strength: 18mcg MDI
Indications/Special comments: Relief of bronchospasm in reversible air ways obstruction, especially COPD and in elderly patients, it has also been used in cystic fibrosis.
Dosage Administration: Chronic asthma or chronic obstructive pulmonary disease: Aerosol inhalation: Adult: 20 - 40 micrograms, in early treatment up to 80 micrograms at a time, 3 - 4 times daily; Child: up to 6 years, 20 micrograms 3 times daily; 6 - 12 years: 20 - 40 micrograms 3 times daily. Inhalers: Adult: 40 micrograms 3 times daily; if necessary, a second dose may be inhaled 5 minutes after the first.